News Archive

Montelukast, commonly used to treat asthma and allergies, is one of five FDA-approved repurposed medications tested in ACTIV-6, a nationwide remote study

May 14, 2024 — Three Duke Clinical Research Institute faculty members were honored by the Duke School of Medicine during the school’s annual faculty awards ceremony on Tuesday, May 14.

May 13, 2024 — The Precision Health Alliance, a new consortium co-founded by the Duke Clinical Research Institute (DCRI), Beam Therapeut

Read insights from a recent DCRI Think Tanks where experts discussed the current state of drug development for chronic health conditions, identified key barriers, and formulated six action items to accelerate drug development.

DCRI will partner with the Duke Margolis Institute for Health Policy and Eli Lilly and Company to understand the metabolic landscape and address disparities.

DCRI is the world’s largest academic clinical research organization and a pioneer in cardiovascular clinical research, combining clinical an

APRIL 15, 2024 — Faculty experts from the Duke Clinical Research Institute (DCRI) shared insights and expertise on the latest cardiology research as part of more than 100 late-breaking

There are often conflicting headlines about whether certain foods are good or bad for you, and the news about eggs has been especially confusing.

About 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. There are limited treatments to prevent or slow that development.